528 Intratumoural treatment with LTX-, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces CD8 effector cells and regression in some injected tumours

Autor:	James Spicer, Jean-François Baurain, A. Saunders, Jalal Vakili, O. Rekdal, Philippe Aftimos, B. Nicolaisen, F. Marjuadi, W.M. Olsen, M. Laruelle, P. Brunsvig, Ahmad Awada, Philippe Barthélémy, S. Deva
Rok vydání:	2015
Předmět:	chemistry.chemical_classification Cancer Research business.industry Effector medicine.medical_treatment Peptide Disease Immunotherapy Oncolytic virus Oncology chemistry Cancer research Medicine In patient business CD8
Zdroj:	European Journal of Cancer. 51:S113
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)30329-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ca5293089edcaac70f798b383fe3c03c https://doi.org/10.1016/s0959-8049(16)30329-x Zobrazit plný text záznamu Full Text from ScienceDirect